Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

LSP raises €280 million for healthcare innovation fund

Country: Netherlands

Netherlands-based LSP (Life Sciences Partners) has raised €280 million in the first and final closing of a new medical technology fund that will invest in companies developing medical devices, diagnostics and applications for digital health. 

Read more

FDA approves first follow-on diabetes drug

Country: United States

The US Food and Drug Administration has approved a follow-on, or biosimilar, medicine for diabetes from Sanofi SA that is intended to improve the control of blood sugar in children and adults with both Type 1 and Type 2 forms of the disease.

Read more

Hookipa raises €50 million for vaccine development

Country: Austria

Read more

Series A funding for Belgian start-up

Country: Belgium

Read more

OSE Immunotherapeutics' trial to reopen

Country: France

Read more

Medigene raises forecast after sale of asset

Country: Germany

Read more

GW Pharma to float US shares

Country: United Kingdom

Read more

GW Pharma annual operating loss soars

Country: United Kingdom

Read more

Semma raises $114 million for diabetes project

Country: United States

Read more

MorphoSys increases financial guidance

Country: Germany

Read more

Siemens plans to list diagnostics business

Country: Germany

Read more

AZ in China joint venture

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The case for value-based pricing by Tara Raveendran

Value-basedpricingTaraRaveendranNovDec2017.pdf

Highlights of the November-December 2017 MedNous issue

The November-December 2017 MedNous features:

Latest Mednous cover
  • Business Strategy
    Europe’s biotech entrepreneurs
  • Public Policy
    The case for value-based pricing
    By Tara Raveendran
  • Research Strategy
    Bill Gates backs Alzheimer’s disease research
    By Jean-Claude Muller
  • Oncology Review
    The rise of single-arm studies
    By Bruno Pagliara
  • Corporate Strategy
    Priorities of the new Novartis CEO
    By Robin Davison
  • Regenerative Medicine
    Commercialising CAR T cell therapies
    By Ravi Nalliah

The latest MedNous journal. Subscribe to download.